Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
I Sold My Home Myself. Here’s How I Set the Price
Key points
- It’s important to set the price of your home just right from the beginning so it doesn’t sit on the market too long or brings you less profit than it could.
- I kept track of other houses in

